Artal Group’s SQZ Biotechnologies Company SQZ Stock Holding History

Artal Group’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,606,309	Closed	-$129K	–	119
2023 Q3	$129K	Hold	1,606,309	–	–	0.01%	99
2023 Q2	$434K	Hold	1,606,309	–	–	0.01%	105
2023 Q1	$900K	Hold	1,606,309	–	–	0.05%	94
2022 Q4	$1.19M	Hold	1,606,309	–	–	0.07%	102
2022 Q3	$3.66M	Hold	1,606,309	–	–	0.16%	72
2022 Q2	$5.11M	Hold	1,606,309	–	–	0.27%	58
2022 Q1	$7.73M	Hold	1,606,309	–	–	0.32%	61
2021 Q4	$14.3M	Hold	1,606,309	–	–	0.39%	57
2021 Q3	$23.2M	Hold	1,606,309	–	–	0.52%	49
2021 Q2	$23.2M	Hold	1,606,309	–	–	0.47%	47
2021 Q1	$22M	Buy	1,606,309 +1	+0%	+$20	0.39%	58
2020 Q4	$46.6M	Buy	+1,606,308	New	+$41M	1%	26

Artal Group's SQZ Position: Q4 2023 in Review

Artal Group sold out of SQZ Biotechnologies Company (SQZ) in Q4 2023, closing a stake of 1,606,309 shares — an estimated $129K sold.

Artal Group first reported a position in SQZ in Q4 2020 and held it in 12 quarters. The position peaked at $46.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold SQZ as of Q4 2023.

Artal Group reported no remaining SQZ Biotechnologies Company position as of Q4 2023 after selling out during the quarter.
Artal Group sold 1,606,309 SQZ Biotechnologies Company shares in Q4 2023, an estimated $129K.
Artal Group first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 12 quarters.
Artal Group's SQZ Biotechnologies Company position peaked at $46.6M in Q4 2020.
0 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q4 2023.

Based on Artal Group's 13F filing for Q4 2023, filed 9 Feb 2024.